Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.


Journal

Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 30 4 2019
medline: 24 3 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Arthropathy is a common and disabling complication of acromegaly. Since in this condition radiological findings rarely correspond to functional impairment, we elected to quantify in a large cohort of acromegalic patients: the degree of motor disability compared with data from general population, the impact of joint involvement on quality of life and work productivity, and to look for associated factors. In 211 acromegalic patients, 131 with controlled disease and 80 with active disease, eight validated scales were used to evaluate the (i) prevalence and distribution of arthropathy, (ii) degree of motor disability and joint symptoms (VAS, AIMS symptoms and WOMAC), (iii) quality of life (AcroQoL and PASQ) and work capability (WPAI:GH) as consequences of joint complications. Using the WOMAC questionnaire, for which population based normative values are available, a significantly higher prevalence and severity of motor disability was detected in acromegalics compared to the general population from literature. The results provided by the different questionnaires turned out to be highly concordant. All measures of motor disability correlated both with impaired quality of life and motor disability and were worse in females and in patients with higher BMI. The questionnaires VAS, AIMS symptoms, and WOMAC (this latter both as a whole and with its functionality subscale), with their scores, proved to be the most adequate tools to evaluate motor disability and its consequences on both quality of life and work productivity in acromegaly. Female gender and higher BMI are associated with worse articular symptoms.

Identifiants

pubmed: 31032537
doi: 10.1007/s11102-019-00966-8
pii: 10.1007/s11102-019-00966-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

552-560

Références

Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
N Engl J Med. 2000 Apr 20;342(16):1171-7
pubmed: 10770982
Osteoarthritis Cartilage. 2003 Aug;11(8):551-60
pubmed: 12880577
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
J Clin Endocrinol Metab. 2004 Feb;89(2):598-603
pubmed: 14764768
Health Qual Life Outcomes. 2004 Feb 27;2:13
pubmed: 14987332
Endocrinol Metab Clin North Am. 1992 Sep;21(3):615-31
pubmed: 1521515
J Clin Endocrinol Metab. 2005 May;90(5):2731-9
pubmed: 15741257
J Endocrinol Invest. 2005;28(8 Suppl):24-31
pubmed: 16323826
Eur J Endocrinol. 2006 Aug;155(2):269-77
pubmed: 16868140
J Clin Endocrinol Metab. 2008 Oct;93(10):3853-9
pubmed: 18647806
Growth Horm IGF Res. 2010 Jun;20(3):226-33
pubmed: 20194043
Clin Exp Rheumatol. 1991 Jan-Feb;9(1):47-50
pubmed: 2054967
Ann Rheum Dis. 2011 Feb;70(2):320-5
pubmed: 21131647
Semin Arthritis Rheum. 2011 Oct;41(2):139-48
pubmed: 21546065
Eur J Endocrinol. 2012 Mar;166(3):407-13
pubmed: 22170798
Eur J Endocrinol. 2012 Aug;167(2):235-44
pubmed: 22645199
Pituitary. 2014 Feb;17(1):44-52
pubmed: 23344976
Clin Rheumatol. 2013 Jul;32(7):991-8
pubmed: 23512376
Growth Horm IGF Res. 2013 Oct;23(5):159-64
pubmed: 23810124
Best Pract Res Clin Rheumatol. 2014 Feb;28(1):5-15
pubmed: 24792942
Neuroendocrinology. 2016;103(1):86-95
pubmed: 25633971
J Rheumatol. 2016 Feb;43(2):433-9
pubmed: 26628608
Eur J Endocrinol. 2017 Jun;176(6):779-790
pubmed: 28348071
Arthritis Rheum. 1988 Aug;31(8):1022-7
pubmed: 2900639
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
Ann Rheum Dis. 1971 May;30(3):243-58
pubmed: 4253632
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Clin Pharmacol Ther. 1983 Aug;34(2):234-9
pubmed: 6872418
Arthritis Rheum. 1982 Sep;25(9):1048-53
pubmed: 7126289
Pain. 1975 Dec;1(4):379-84
pubmed: 800639

Auteurs

L M Fatti (LM)

Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.

B Cangiano (B)

Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

G Vitale (G)

Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

L Persani (L)

Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

G Mantovani (G)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Endocrine Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

E Sala (E)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Endocrine Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

M Arosio (M)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Endocrine Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

P Maffei (P)

Department of Medicine-DIMED, University of Padua, Padua, Italy.

F Dassie (F)

Department of Medicine-DIMED, University of Padua, Padua, Italy.

M Mormando (M)

Pituitary Unit, Section of Endocrinology, Department of Internal Medicine, Catholic University, 'A. Gemelli' University Hospital, Rome, Italy.

A Giampietro (A)

Pituitary Unit, Section of Endocrinology, Department of Internal Medicine, Catholic University, 'A. Gemelli' University Hospital, Rome, Italy.

L Tanda (L)

Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.

E R Masiello (ER)

Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.

E Nazzari (E)

Endocrinology Unit, Department of Internal Medicine and Medical Specialties, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.

D Ferone (D)

Endocrinology Unit, Department of Internal Medicine and Medical Specialties, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.

S Corbetta (S)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

E Passeri (E)

Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

F Guaraldi (F)

Pituitary Unit, Department of Biomedical and Neuromotor Sciences, IRCCS Institute of Neurological Sciences of Bologna, University of Bologna, Bologna, Italy.

S Grottoli (S)

Department of Medical Sciences, University of Turin, Turin, Italy.

S Cannavò (S)

Department of Human Pathology, University of Messina, Messina, Italy.
Endocrine Unit, University Hospital of Messina, Messina, Italy.

M L T Torre (MLT)

Department of Human Pathology, University of Messina, Messina, Italy.

D Soranna (D)

Istituto Auxologico Italiano, IRCCS, Milan, Italy.

A Zambon (A)

Division of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

F Cavagnini (F)

Istituto Auxologico Italiano IRCCS, Center for Biomedical Research and Technology, Cusano Milanino, Milan, Italy.

M Scacchi (M)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. massimo.scacchi@unimi.it.
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, Ospedale S. Giuseppe, Strada Cadorna 90, 28824, Località Piancavallo, Oggebbio-Verbania, Italy. massimo.scacchi@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH